Search research articles
Contact Us
Filters
Showing results (331-340 of 336) with videos related to
Page
of 34
Sort By:
You have reached the last page of results.
This site can display upto 336 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 20, 2014
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†
F Cardoso, A Costa, L Norton, et al.
Breast (Edinburgh, Scotland)
|
September 24, 2014
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
F Cardoso, A Costa, L Norton, et al.
Bioanalysis
|
January 25, 2025
2024 White Paper on Recent Issues in Bioanalysis: Evolution of Immunogenicity Assessment beyond ADA/NAb; Regulated Genomic/NGS Assays; Hypersensitivity Reactions; Minimum Noise Reduction; False Positive Range; Modernized Vaccine Approaches; NAb/TAb Correlation <u>(PART 3A</u> - Recommendations on Advanced Strategies for Molecular Assays and Immunogenicity of Gene Therapy, Cell Therapy, Vaccine; Biotherapeutics Immunogenicity Assessment & Clinical Relevance <u>PART 3B</u> - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies)
Omar Tounekti, Sandra Prior, Sarah Wassmer, et al.
Bioanalysis
|
January 6, 2026
2025 White Paper on Recent Issues in Bioanalysis: Redosing Patients with AAV Gene Therapy; CRS Immunogenicity Risk; Shedding Assays; NHP Studies Immunogenicity; CMC vs Bioanalytical Assays; Artificial Intelligence-Powered Genomic Pipelines for NGS (<u>PART 3A</u> - Recommendations on Gene, Cell, and Vaccine Therapies Immunogenicity & Technologies; Biotherapeutics & Biosimilars Immunogenicity Assessment & Clinical Relevance <u>PART 3B</u> - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies)
Omar Tounekti, Sophie Shubow, Sarah Wassmer, et al.
Bioanalysis
|
May 17, 2022
2021 White Paper on Recent Issues in Bioanalysis: ISR for Biomarkers, Liquid Biopsies, Spectral Cytometry, Inhalation/Oral & Multispecific Biotherapeutics, Accuracy/LLOQ for Flow Cytometry (<u>Part 2</u> - Recommendations on Biomarkers/CDx Assays Development & Validation, Cytometry Validation & Innovation, Biotherapeutics PK LBA Regulated Bioanalysis, Critical Reagents & Positive Controls Generation)
Sarah Hersey, Steve Keller, Joel Mathews, et al.
Nature
|
November 16, 2018
Improved reference genome of Aedes aegypti informs arbovirus vector control
Benjamin J Matthews, Olga Dudchenko, Sarah B Kingan, et al.
Page
of 34
Search research articles
Search
Showing results (331-340 of 336) with videos related to
Sort By:
Page
of 34
You have reached the last page of results.
This site can display upto 336 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 20, 2014
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†
F Cardoso, A Costa, L Norton, et al.
Breast (Edinburgh, Scotland)
|
September 24, 2014
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
F Cardoso, A Costa, L Norton, et al.
Bioanalysis
|
January 25, 2025
2024 White Paper on Recent Issues in Bioanalysis: Evolution of Immunogenicity Assessment beyond ADA/NAb; Regulated Genomic/NGS Assays; Hypersensitivity Reactions; Minimum Noise Reduction; False Positive Range; Modernized Vaccine Approaches; NAb/TAb Correlation <u>(PART 3A</u> - Recommendations on Advanced Strategies for Molecular Assays and Immunogenicity of Gene Therapy, Cell Therapy, Vaccine; Biotherapeutics Immunogenicity Assessment & Clinical Relevance <u>PART 3B</u> - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies)
Omar Tounekti, Sandra Prior, Sarah Wassmer, et al.
Bioanalysis
|
January 6, 2026
2025 White Paper on Recent Issues in Bioanalysis: Redosing Patients with AAV Gene Therapy; CRS Immunogenicity Risk; Shedding Assays; NHP Studies Immunogenicity; CMC vs Bioanalytical Assays; Artificial Intelligence-Powered Genomic Pipelines for NGS (<u>PART 3A</u> - Recommendations on Gene, Cell, and Vaccine Therapies Immunogenicity & Technologies; Biotherapeutics & Biosimilars Immunogenicity Assessment & Clinical Relevance <u>PART 3B</u> - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies)
Omar Tounekti, Sophie Shubow, Sarah Wassmer, et al.
Bioanalysis
|
May 17, 2022
2021 White Paper on Recent Issues in Bioanalysis: ISR for Biomarkers, Liquid Biopsies, Spectral Cytometry, Inhalation/Oral & Multispecific Biotherapeutics, Accuracy/LLOQ for Flow Cytometry (<u>Part 2</u> - Recommendations on Biomarkers/CDx Assays Development & Validation, Cytometry Validation & Innovation, Biotherapeutics PK LBA Regulated Bioanalysis, Critical Reagents & Positive Controls Generation)
Sarah Hersey, Steve Keller, Joel Mathews, et al.
Nature
|
November 16, 2018
Improved reference genome of Aedes aegypti informs arbovirus vector control
Benjamin J Matthews, Olga Dudchenko, Sarah B Kingan, et al.
Page
of 34